-
Track & Monitor
NewClinical Trials Feasibility Risk Assessment and Planning for Success – A Depression Case Study
This report provides the global clinical trial landscape for depression and identifies key analysis of the main features in order to run similar trials successfully. As the prevalence of depression has increased, the outlook of it has also changed in positive ways. Better support and services for depression as well as the increase of discussing this order has lead to an increase of depression clinical trials. The COVID-19 pandemic has played a major role in that.
-
Product Insights
NewGaucher Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Gaucher Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Gaucher Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Gaucher Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 &...
-
Product Insights
NewTurner Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Turner Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Turner Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Turner Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 &...
-
Product Insights
NewMyelodysplastic Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Myelodysplastic Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Myelodysplastic Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Myelodysplastic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 &...
-
Product Insights
NewAtopic Dermatitis (Atopic Eczema) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Atopic Dermatitis (Atopic Eczema) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Atopic Dermatitis (Atopic Eczema) Clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic Dermatitis (Atopic Eczema). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical...
-
Product Insights
NewMeningitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Meningitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Meningitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Meningitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial...
-
Product Insights
NewVentilator Associated Pneumonia (VAP) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Ventilator Associated Pneumonia (VAP) Clinical trials scenario. This report provides top line data relating to the clinical trials on Ventilator Associated Pneumonia (VAP). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical...
-
Product Insights
NewLennox-Gastaut Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Lennox-Gastaut Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Lennox-Gastaut Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Lennox-Gastaut Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 &...
-
Product Insights
NewCutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Cutaneous Lupus Erythematosus Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Cutaneous Lupus Erythematosus Clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region,...
-
Product Insights
NewKeratoconjunctivitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Keratoconjunctivitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Keratoconjunctivitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Keratoconjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial...
-
Product Insights
NewGall Stone Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Gall Stone Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Gall Stone Clinical trials scenario. This report provides top line data relating to the clinical trials on Gall Stone. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 &...
-
Sector Analysis
NewHeart Failure Epidemiology Analysis and Forecast to 2032
Heart Failure Report Overview In the 7MM, there were 3,094,817 diagnosed incident cases of heart failure in 2022. The market is expected to grow at an AGR of more than 1% during 2022-2032. The Heart Failure market research report provides an overview of the risk factors, comorbidities, and global and historical epidemiological trends for heart failure in the seven major markets namely the US, France, Germany, Italy, Spain, UK, and Japan. The report also includes a 10-year epidemiology forecast for...
-
Track & Monitor
NewGenomics in pharma: T-cell culturing
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the pharma industry’s T-cell culturing within Genomics innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and...
-
Track & Monitor
NewImmuno-oncology in pharma: oncolytic viral proteins
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the pharma industry’s oncolytic viral proteins within Immuno-oncology innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge...
-
Track & Monitor
NewImmuno-oncology in Pharmaceuticals: Cancer chimeric antigen receptor (CAR) T-cell therapy
Innovation in the pharmaceuticals industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in pharmaceuticals industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Sector Analysis
NewIdiopathic Hypersomnia (IH) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Idiopathic Hypersomnia (IH) Marketed and Pipeline Drugs Report Overview Idiopathic Hypersomnia (IH) is a rare chronic sleep disorder with the primary complaint being the irresistible need to sleep and waking up non-refreshed despite the prolonged duration of sleep, for at least three months. IH belongs to the primary sleep disorder category of hypersomnia. Primary hypersomnia includes narcolepsy type 1 and type 2, and Kleine-Levin syndrome, which commonly occurs in teenage males along with IH. Key Mechanism of Action (Marketed) ·      ...
-
Sector Analysis
NewDiabetic Nephropathy (DN) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Diabetic Nephropathy (DN) Marketed and Pipeline Drugs Report Overview Diabetic Nephropathy (DN) is glomerular sclerosis and fibrosis caused by the metabolic and hemodynamic changes of diabetes mellitus (DM). It manifests as slowly progressive albuminuria with worsening hypertension and renal insufficiency. DN is the most common cause of nephrotic syndrome in adults and is also the most common cause of end-stage renal disease (ESRD) in the US, accounting for up to 80% of cases. Renal failure is particularly common in certain...
-
Sector Analysis
NewIgA Nephropathy (Berger’s Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
IgA Nephropathy (Berger’s Disease) Marketed and Pipeline Drugs Report Overview IgA Nephropathy (Berger's disease) is an autoimmune disease that occurs when clumps of antibodies are deposited in the kidneys, causing inflammation and kidney damage. Clumps of IgA and other antibodies damage the glomeruli, tiny blood vessels in the kidneys that filter blood, causing the kidneys to leak blood and protein into the urine. The damage may also lead to scarring of the nephrons, the filtering units where the glomeruli are...
-
Product Insights
NewSocial Anxiety Disorder (SAD/Social Phobia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Social Anxiety Disorder (SAD/Social Phobia) Clinical Trials Market Report Overview The social anxiety disorder (SAD/social phobia) trial market research report provides an overview of the social anxiety disorder (SAD/social phobia) trials scenario. The report provides top-line data relating to the clinical trials on social anxiety disorder. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
NewDry (Atrophic) Macular Degeneration Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Dry (Atrophic) Macular Degeneration Clinical Trials Market Report Overview The dry (atrophic) macular degeneration clinical trial market research report provides an overview of the dry (atrophic) macular degeneration clinical trials scenario. The report provides top-line data relating to the clinical trials on dry (atrophic) macular degeneration. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.